CFTR and cystic fibrosis: A separate study corroborated these findings and found that MDMs from people with CF and ivacaftor-sensitive CFTR variants had improved phagocytosis, reduced apoptosis, and decreased pro-inflammatory cytokines after ivacaftor treatment.